如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)
阿贝西利联合帕博利珠单抗治疗 HR+、HER2- 转移性乳腺癌：1b 期研究
返回Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study
作者:Hope S. Rugo, Peter Kabos, J. Thad Beck, Guy Jerusalem, Hans Wildiers, Elena Sevillano, Luis Paz-Ares, Michael J. Chisamore, Sonya C. Chapman, Anwar M. Hossain, Yanyun Chen & Sara M. Tolaney 期刊:Breast Cancer 发表日期:2022-11-05卷/期/页码:8, Article number: 118 (2022)
